| Tag | Content |
|---|
EnhancerAtlas ID | HS018-01585 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr1:161580840-161583160 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | TFAP2A | MA0003.3 | chr1:161581075-161581086 | CGCCTCAGGCT | + | 6.14 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161581253 | 161581372 | | chr1 | 161582212 | 161582506 | | chr1 | 161581400 | 161582169 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | ACAAGTTGCA AAGATACTAC ATAAAGTTAT TACTCTATAT CCTTTCTACT TCCCCTAATG 60
TTAAAACCTT ACATAACCAT GTTATATTTA TCAAACCTAA GAAATTGGCA TTGGTATAAC 120
ATTAATGACT TTTTTTTTTT TTTTTGGACA CAGGGTCTCA CTCTGTACCC CAGCCTGGAG 180
TGCAGTGGCA CGATCTCGGC TCACTGCAAC CTCTGCCCCC TGGGCTCAAG AGATTCGCCT 240
CAGGCTCCCG GAGTAGCTGG GACTACAGGC GCGAACCCCG GGTACTTGGG AGGCTGAGGC 300
ACGAGAACCG CGTGGACCGG GAAGACGGAG GCTGCAGTGA GCCAAGATCG CGCCACAGTA 360
CTCCAGCCTG GGGTACAGAG TGAGAACCTG TCTCAAAAAA AAAAAAAAAA AAGCTGGGGA 420
GCGGGGCAAG GCGGTGGAGA ATCTGATCCT TACCAAAGTT TGACACTACT GCGTTAGCGT 480
TAAAAAAAAA ACCCAGCTAA GACTGTAGAG CAAATTAAAG GATCCTGTGT TGAGGGCGTT 540
CTCTTGTTTA GTCAAAGGAG ATGGTATCTG CCTGCCTTAG TGTGCTTGAC GCACAGAAAG 600
GGCTCAACAC ATTGTTGTTG AATAAAAGAA TGGATAAATT GACACTGGGA AGTTGGAGTC 660
CAAAGTTAAA CTTAGTCTCA ACTGCTCCCT GTTTTCATAG ACCAGACTCC AGCCTACAAT 720
ACAGGAAAAA TAGATTTAGT TCTATATGTG CAGAGAAGCA CAAATAATTT TCGTAAATGT 780
AGATACCCAG GATAAAACGC AGTGTTGACC GATCGAAAAG TCTTTCTCTA AGAATTCAAA 840
CATAATTGCT GGTTGGTTCA AATCAGGAGG AAAAGTAAGG ATGGAAAACA TACGTTGTCA 900
AAAGTGGGAT TCGAACCCAC GCCTCCAGCG GAGGGTGCGA TTTGAACGCA GCGCCTTAAG 960
ACTGCTCGGC CATCCTGACA CACGTTTTGC TAAACTTCCT AATTTCTCCT AATTTTATCA 1020
TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC TATTTACTGT TTCAAATAAA 1080
ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA TGAAACAGCC TCCGACAGCT 1140
CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT CCATTTTCCC TGGCGACTCT 1200
TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT CAAGGTAGAC CCTGTGTCGG 1260
CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG AATCCGACAC CCGGCGGATC 1320
CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG GGACATGAGG AGTGCGGGGG 1380
GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC AACTGCGGCT TTCTCTCTCG 1440
GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG GCTTCTGCGT TCACCGCCCC 1500
CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT CTCACCAATG GAGGGCTTAG 1560
CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG AACGGTCGGG AAAGTCATAC 1620
GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC CGGGGACGCG TTGGTGGTGT 1680
AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT TCGATTCCCG GGTAACGAAA 1740
CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG GAGCCTCCAG CGCGCTGTGT 1800
ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC TTTCCGTACT CGCTTCCTGT 1860
CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA GGGATTAAAT TCTGATGGTT 1920
CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA GGAATCTTTG GGATCATTTC 1980
AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT GTCTTCACTT GCGAGGTTCA 2040
TTCGCTAGCC TCTACAAATC ATCACTTAAG CCCCTAATTA TTCCCGGCCG AGGTCCTAGG 2100
CTAAGGTCCC GGGCCAAGCT TTCTAATTAG TCCCAGGCCA AGGTCCCAGG CCAACCTAAA 2160
TCACGCATTC TCCAAAACAG CCGGCAAACT AAGCACATTC CTTCCCGTTT CCAGTCCATA 2220
AACCCCCCCC CCCAAGTGGC CTCATAGTAA GCAACTCATT CGGGCCCCCT CTCTGCTGGC 2280
AAAAAGCTCA GATGTACTGG ACTGTGCATT TGATTTGGAA 2320
|
